Benzinga - Feed Your Mind.

Benzinga Professional.

Free Streaming News

BMRN 38.65 0.13 / BioMarin Pharmaceuticals, Inc. Upgrades

Monday, March 19, 2012

UPDATE: Brean Murray Carret Upgrades BioMarin Pharmaceutical to Buy (Analyst Color, BMRN, Upgrades, Price Target, Intraday Update, Analyst Ratings / Mon, 12:12pm)
Benzinga's Top Upgrades (ABT, BMRN, PWRD, UPS, Upgrades, Analyst Ratings / Mon, 07:25am)

Wednesday, September 28, 2011

UPDATE: Deutsche Bank Upgrades BioMarin Pharmaceuticals to Buy (Analyst Color, BMRN, Upgrades, Price Target, Analyst Ratings / Wed, 08:35am)
Deutsche Bank Upgrades BioMarin Pharmaceuticals to Buy, PT Raised to $40 (BMRN, Upgrades, Price Target, Analyst Ratings / Wed, 06:09am)

Wednesday, August 10, 2011

UPDATE: Piper Jaffray Upgrades BioMarin To Overweight (Analyst Color, BMRN, Upgrades, Analyst Ratings / Wed, 09:05am)
Piper Jaffray Upgrades BioMarin To Overweight, Raises PT To $33 (BMRN, Upgrades, Price Target, Analyst Ratings / Wed, 07:17am)

From Benzinga's Newsdesk

Realtime News With Pro

05:22 AM Koesterich Bullish On Dividend ETFs (HDV, DVYE, DVY)
1:21 AM Benzinga's M&A Chatter for Friday May 25, 2012
8:54 PM S&P 500 Futures at 1324.95, +0.76%
12:47 PM Benzinga's Microcap Movers for Friday May 25, 2012
08:37 AM Earnings Expectations for the Week of May 28 (JOY, SAI, TIVO)
08:05 AM Barron's Recap (5/26/12): The Top 50 Annuities, and Tech Firms Hoard Cash
04:52 PM German Solar Power Plants Produce 50% of the Nation's Electric Energy On Saturday
11:50 AM Research in Motion to Eliminate 2,000 Jobs -Globe and Mail
07:55 PM Klafter Olsen & Lesser Files Class Action against Facebook
7:17 PM Amarin Patent 598 to Be Announced as Officially Issued on May 29
05:05 PM Rite Aid Names John T. Standley Board Chairman
4:45 PM Quest Software Spokesperson is Not Commenting on Report of Deal with Dell as Early as This Weekend
4:43 PM DepoMed Files $100M Mixed Securities Shelf
04:37 PM Albemarle to Increase Ibuprofen Prices
04:34 PM Tranzyme Announces Data Show ULISES 008 Did Not Meet Primary and Secondary Endpoints

Store Professional

Latest from Premium

Brain Trust

Options in Portfolio Allocation:...

Michael Thomsett

More from Michael Thomsett:

Orbitz Worldwide: Its Symbol Says...

Ted Allrich

More from Ted Allrich:

Are Taxes Too Low in the USA?

Barbara Friedberg

More from Barbara Friedberg:

Will the New York Times' ever is...

William K. Black

More from William K. Black:

The Real Deal on Wall Street: 5...

Brian Sozzi

More from Brian Sozzi:

The Facebook IPO: What's Not to...

Michael Prus

More from Michael Prus:

DOW Reversal Predicted by the...

Stephen Bigalow

More from Stephen Bigalow:

Will The Real Housing Market Up?...

Logan Mohtashami

More from Logan Mohtashami:

Financial Careers and Career - of...

George Mentz

More from George Mentz:

Adapting for Traders

Adrienne Toghraie

More from Adrienne Toghraie:

iPad Future Growth

Daniel Ho

More from Daniel Ho:

Insider Sentiment is Neutral to...

Nejat Seyhun

More from Nejat Seyhun:

7 Deadly Sins of Investing: Don't...

Jay Peroni

More from Jay Peroni: